cash up front or take over is very near

the company has $1.7mil in the bank as 30 June, that's before it started on the Phase 2 study (BIT225-008) of BIT 225, the Company’s lead antiviral drug with preliminary data available during the second half of the year. one has to assume by 30 Sep, the bank will be running close to empty. one also can presume no bio company will run out of money in the mid of the trial, miner can stop digging, bio cannot stop using drugs ...

my experience tells me if a bio company's bank thinner than my patience, and sp is steadily going upwards, there is very high chance of JV or takeover at the front door... hopefully they are knocking before 10am today so my patience wont be thinner again as well as bit's bank.